CODX vs REG
Co-Diagnostics, Inc. Common Stock (CODX) versus Regency Centers Corporation (REG) — a side-by-side from cached financials, not a winner call.
Co-Diagnostics, Inc. Common Stock (CODX) is a medical devices company listed on US.
Regency Centers Corporation (REG) is a reit - retail company listed on US.
Latest reported CODX revenue for 2024-12-31 was $3.9M. Net income was -$37.6M. Revenue was down 42.5% from 2023-12-31 to 2024-12-31. CODX currently screens at market cap $31.4M.
REG does not have a complete income-statement cache yet.
CODX currently screens at market cap $31.4M. REG currently screens at market cap $12.93B and trailing P/E 33.5.
Not investment advice. Open the CODX and REG stock pages for the full models.
Not investment advice.